Resources
Effective Study Design and Execution of Renal and Hepatic Impairment Trials
As most medications are primarily excreted through the kidneys or liver, most drugs in development will require a renal ...
How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator
In today’s rapidly evolving pharmaceutical landscape, cognitive safety is emerging as a critical factor that can set ...
From Chance Discovery to Molecular Biology
Dr. Sheldon H. Preskorn's presentation, "From Chance Discovery to Molecular Biology," highlights the evolution of ...
Accelerating Clinical & Drug Development Timelines with AI
As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, ...
Updates on Human Abuse Potential Studies: Challenges and Regulatory Guidelines
Discover this groundbreaking webinar delving into the latest insights from the CCALC and the FDA in drug development and clinical evaluation of human drug abuse and dependence potential.